STAT+: Sandoz to pay $478.5 million to settle price-fixing allegations in long-running battle with states

Sandoz agreed to pay $478.5 million to settle allegations that the company engaged in a conspiracy to artificially inflate and manipulate prices.

Sandoz has reached settlement agreements in the long-running US generic drug litigation involving 43 US states and territories, as well as a group of indirect resellers. The Basel-based pharmaceutical group will pay a total of just under $480 million as part of the settlement. The payments will be spread over seven yea

Sandoz to Pay Around $480 Million to Settle U.S. Antitrust Pricing Litigations  wsj.com